Jin Medical International Ltd. revenue
Jin Medical International Ltd.'s revenue was $20.7m in fiscal 2025, down 12.0% on the year before. Since fiscal 2021 ($20.8m) it has grown at a compound -0.1% a year.
Revenue history
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Jin Medical International Ltd. | $20.7m | -12.0% | — |
| Nephros Inc | $20.7m | 24.2% | 19.3% |
| Vivos Therapeutics, Inc. | $20.9m | 45.2% | 10.6% |
| Sonoma Pharmaceuticals, Inc. | $21.9m | 47.0% | 19.9% |
| Baird Medical Investment Holdings Ltd | $22.5m | -39.2% | — |
| Sensus Healthcare, Inc. | $17.5m | -53.4% | -16.5% |
Compare with peers
- Nephros Inc revenue
- Vivos Therapeutics, Inc. revenue
- Sonoma Pharmaceuticals, Inc. revenue
- Baird Medical Investment Holdings Ltd revenue
- Sensus Healthcare, Inc. revenue
Head to head: NEPH vs ZJYLVVOS vs ZJYLSNOA vs ZJYLSRTS vs ZJYL
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies